Bruker Corp BRKR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BRKR is a good fit for your portfolio.
News
-
Access Reminder for Bruker Investor Webinar on May 17, 2024
-
Bruker Announces Quarterly Dividend
-
Bruker Corporation to Host Investor Webinar on May 17, 2024
-
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
-
Bruker Completes Asset Acquisition of NanoString Business
-
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
-
Bruker Reports First Quarter 2024 Financial Results
-
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
Trading Information
- Previous Close Price
- $75.82
- Day Range
- $71.14–79.38
- 52-Week Range
- $53.80–94.80
- Bid/Ask
- $75.23 / $75.31
- Market Cap
- $10.93 Bil
- Volume/Avg
- 1.3 Mil / 938,396
Key Statistics
- Price/Earnings (Normalized)
- 30.70
- Price/Sales
- 3.71
- Dividend Yield (Trailing)
- 0.26%
- Dividend Yield (Forward)
- 0.26%
- Total Yield
- 1.33%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 9,707
- Website
- https://www.bruker.com
Comparables
Valuation
Metric
|
BRKR
|
MASS
|
AZTA
|
---|---|---|---|
Price/Earnings (Normalized) | 30.70 | — | 122.24 |
Price/Book Value | 7.79 | 1.44 | 1.26 |
Price/Sales | 3.71 | 4.40 | 4.64 |
Price/Cash Flow | 27.09 | — | 57.24 |
Price/Earnings
BRKR
MASS
AZTA
Financial Strength
Metric
|
BRKR
|
MASS
|
AZTA
|
---|---|---|---|
Quick Ratio | 0.92 | 7.33 | 4.81 |
Current Ratio | 1.80 | 8.37 | 5.86 |
Interest Coverage | 33.50 | — | — |
Quick Ratio
BRKR
MASS
AZTA
Profitability
Metric
|
BRKR
|
MASS
|
AZTA
|
---|---|---|---|
Return on Assets (Normalized) | 8.97% | −11.93% | −0.57% |
Return on Equity (Normalized) | 28.26% | −14.51% | −0.65% |
Return on Invested Capital (Normalized) | 13.98% | −18.25% | −2.14% |
Return on Assets
BRKR
MASS
AZTA
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Yvqtghgb | Nrpbpx | $182.4 Bil | |
SYK
| Stryker Corp | Flxyhrvd | Cyc | $127.2 Bil | |
MDT
| Medtronic PLC | Fnphbjvrh | Bcxplf | $113.7 Bil | |
BSX
| Boston Scientific Corp | Rbfqdgzn | Crcnjzw | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Qmdlztbz | Cktqyn | $54.3 Bil | |
DXCM
| DexCom Inc | Yzxnvhyl | Ytzz | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Dzzghmfj | Kszfxv | $25.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Lssbzymyn | Wxnk | $24.9 Bil | |
ALGN
| Align Technology Inc | Jbpfvdtjk | Kjvlytp | $20.6 Bil | |
SNN
| Smith & Nephew PLC ADR | Trhdbmb | Wxynrj | $11.4 Bil |